Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Niagen+ Announces U.S. FDA Approval of ChromaDex’s First Pharmaceutical-Grade Injectable Niagen®
ChromaDex has announced the launch of Niagen+, the first pharmaceutical-grade Niagen® (patented nicotinamide riboside chloride or NRC). Approved by the U.S. FDA for compounding by 503B outsourcing facilities, this intravenous (IV) and injectable NRC will be available in shot and push forms exclusively at clinics with a prescription....
Epigenica Introduces New Epigenetics Platform and Pioneering ChIP-seq Kit for Comprehensive Genome Profiling
Epigenica has launched the EpiFinder™ Platform, incorporating its patented hmqChIP-seq technology for high-throughput, multiplexing ChIP-seq applications. The flagship product, EpiFinder Genome, is the first commercial kit that allows simultaneous profiling of up to eight markers...
U.S. FDA Grants Breakthrough Therapy Designation to Bayer’s BAY 2927088
Bayer announced that the Centre for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) and the U.S. FDA have granted Breakthrough Therapy designation to BAY 2927088. This investigational drug is intended for adults with unresectable or metastatic non-small cell lung...
Vera Therapeutics' Atacicept Receives FDA Breakthrough Therapy Designation for IgAN
Vera Therapeutics, a biotechnology company specializing in treatments for serious immunological conditions, has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for atacicept...
NUS Scientists Develop Breakthrough Magnetic Pulse Technique to Activate Muscle Cells to Fight Cancer
Researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovation & Technology (iHealthtech) have introduced a novel method that uses brief, mild pulsed electromagnetic fields to stimulate...
FDA Approves Milestone Pharmaceuticals' NDA for CARDAMYST™ Therapy
Milestone® Pharmaceuticals, a company focused on cardiovascular treatments, announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) for CARDAMYST (etripamil) nasal spray. ...
Roche received FDA Breakthrough Designation for Inavolisib in HR-Positive, HER2-Negative Breast Cancer
Roche has received Breakthrough Therapy Designation from the U.S. FDA for inavolisib, an investigational oral therapy, combined with palbociclib (Ibrance®) and fulvestrant. ...
Avidity Biosciences Delpacibart Etedesiran Receives FDA Breakthrough Therapy Designation for Myotonic Dystrophy Type 1
Avidity Biosciences, a company specializing in RNA therapeutics, has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to delpacibart etedesiran (AOC 1001)....
Penn Researchers Create Breakthrough Method for Designing Human Artificial Chromosomes
Researchers at the Perelman School of Medicine at the University of Pennsylvania have achieved a significant breakthrough in the field of human artificial chromosomes (HACs), potentially transforming gene therapies and laboratory research....
FDA Grants Breakthrough Designation to Soleno's Diazoxide Choline for Prader-Willi Syndrome
Soleno Therapeutics, a company specializing in treatments for rare diseases, has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to diazoxide choline....
